BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

67 related articles for article (PubMed ID: 25313751)

  • 1. An evaluation of nuclear factor kappa B expression in colorectal carcinoma: an analysis of 50 cases.
    Moorchung N; Kunwar S; Ahmed KW
    J Cancer Res Ther; 2014; 10(3):631-5. PubMed ID: 25313751
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The usefulness of immunohistochemistry in sporadic colorectal cancer.
    Vrabie CD; Ceauşu M; Petrescu A; Waller M; Dina I
    Rom J Morphol Embryol; 2008; 49(4):525-35. PubMed ID: 19050802
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Regulation of TRAIL receptor expression by β-catenin in colorectal tumours.
    Jalving M; Heijink DM; Koornstra JJ; Boersma-van Ek W; Zwart N; Wesseling J; Sluiter WJ; de Vries EG; Kleibeuker JH; de Jong S
    Carcinogenesis; 2014 May; 35(5):1092-9. PubMed ID: 24379239
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Increased nuclear factor-kB activation in human colorectal carcinoma and its correlation with tumor progression.
    Kojima M; Morisaki T; Sasaki N; Nakano K; Mibu R; Tanaka M; Katano M
    Anticancer Res; 2004; 24(2B):675-81. PubMed ID: 15161011
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Comparison of tumor grade and stage with nuclear factor kappa b and p38 mitogene activated protein kinase expressions in renal cell cancer.
    Ozbek E; Aliskan T; Otunctemur A; Calik G; Cakir S; Dursun M; Somay A
    Arch Ital Urol Androl; 2012 Jun; 84(2):53-60. PubMed ID: 22908772
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Immunoreactivity evaluation of mutant p53 gene product with DNA ploidy pattern in colorectal carcinoma.
    Nasif WA; El-Emshaty HM; Tabll A; Elmasry SA; Attallah AM; Gad Elhak NA
    Hepatogastroenterology; 2004; 51(58):1001-6. PubMed ID: 15239234
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Nuclear factor-kappa B regulates cyclooxygenase-2 expression and cell proliferation in human colorectal carcinoma tissue.
    Yu LL; Yu HG; Yu JP; Luo HS
    Eksp Onkol; 2004 Mar; 26(1):40-7. PubMed ID: 15112579
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Astrocyte elevated gene-1 interacts with β-catenin and increases migration and invasion of colorectal carcinoma.
    Zhang F; Yang Q; Meng F; Shi H; Li H; Liang Y; Han A
    Mol Carcinog; 2013 Aug; 52(8):603-10. PubMed ID: 22431469
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Constitutive NF-kappaB activation in colorectal carcinoma plays a key role in angiogenesis, promoting tumor growth.
    Sakamoto K; Maeda S; Hikiba Y; Nakagawa H; Hayakawa Y; Shibata W; Yanai A; Ogura K; Omata M
    Clin Cancer Res; 2009 Apr; 15(7):2248-58. PubMed ID: 19276252
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Mechanism of expression and role in transcriptional control of the proto-oncogene NFKB-2/LYT-10.
    Chang CC; Zhang J; Lombardi L; Neri A; Dalla-Favera R
    Oncogene; 1994 Mar; 9(3):923-33. PubMed ID: 8108136
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Clinical significance of costimulatory molecule B7-H3 expression on CD3(+) T cells in colorectal carcinoma.
    Mao Y; Sun J; Wang WP; Zhang XG; Hua D
    Chin Med J (Engl); 2013 Aug; 126(16):3035-8. PubMed ID: 23981607
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Expression of p53 in colorectal carcinoma: correlation with clinicopathologic features.
    Ghavam-Nasiri MR; Rezaei E; Ghafarzadegan K; Seilanian-Toosi M; Malekifard H
    Arch Iran Med; 2007 Jan; 10(1):38-42. PubMed ID: 17198452
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Significance of intratumoral microvessel density quantification based on immunohistochemical detection of PECAM-1 and vWF in colorectal carcinoma from Iraqi patients.
    Ahmed MM; Mohammed SH
    Indian J Pathol Microbiol; 2010; 53(3):439-46. PubMed ID: 20699499
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Immunohistochemical expression of P53 and oncogenes in ulcerative colitis-associated colorectal carcinoma.
    Brüwer M; Schmid KW; Senninger N; Schürmann G
    World J Surg; 2002 Mar; 26(3):390-6. PubMed ID: 11865380
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Expression of CARD6, an NF-kappaB activator, in gastric, colorectal and oesophageal cancers.
    Kim SS; Ahn CH; Kang MR; Kim YR; Kim HS; Yoo NJ; Lee SH
    Pathology; 2010 Jan; 42(1):50-3. PubMed ID: 20025480
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Protein expression of NF-kappaB in human colorectal adenocarcinoma.
    Evertsson S; Sun XF
    Int J Mol Med; 2002 Nov; 10(5):547-50. PubMed ID: 12373289
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Cytokeratin 20 and vascular endothelial growth factor as molecular markers in Egyptian patients with colorectal cancer.
    Auf FA; El-Eibdy GK; Mosaad YM; El-Ghannam DM; El-Masry EE
    J Oncol Pharm Pract; 2011 Sep; 17(3):160-7. PubMed ID: 20395351
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The combination of nuclear factor kappa B, cyclo-oxygenase-2 and vascular endothelial growth factor expression predicts poor prognosis in stage II and III colorectal cancer.
    Kim NK; Park JK; Shin E; Kim YW
    Anticancer Res; 2014 Nov; 34(11):6451-7. PubMed ID: 25368245
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Human leukocyte antigen-E protein is overexpressed in primary human colorectal cancer.
    Levy EM; Bianchini M; Von Euw EM; Barrio MM; Bravo AI; Furman D; Domenichini E; Macagno C; Pinsky V; Zucchini C; Valvassori L; Mordoh J
    Int J Oncol; 2008 Mar; 32(3):633-41. PubMed ID: 18292941
    [TBL] [Abstract][Full Text] [Related]  

  • 20. TUFM is a potential new prognostic indicator for colorectal carcinoma.
    Shi H; Hayes M; Kirana C; Miller R; Keating J; Macartney-Coxson D; Stubbs R
    Pathology; 2012 Oct; 44(6):506-12. PubMed ID: 22772342
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.